Johns Hopkins ABX Guide
Valganciclovir
INDICATIONS
FDA
FDA
- Treatment of CMV retinitis (AIDS).
- Prevention of CMV disease: renal, cardiac and kidney-pancreas transplant patients at high risk for CMV disease (e.g., donor positive, recipient negative).
- Not indicated in liver transplant patients.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Prevention of disseminated CMV disease of the contralateral eye in patients treated with intraocular ganciclovir implant (no longer manufactured).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: April 11, 2017
Citation
Pham, Paul A, et al. "Valganciclovir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540577/10/Valganciclovir.
Pham PA, Dzintars K, Hsu AJ. Valganciclovir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540577/10/Valganciclovir. Accessed June 8, 2023.
Pham, P. A., Dzintars, K., & Hsu, A. J. (2017). Valganciclovir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540577/10/Valganciclovir
Pham PA, Dzintars K, Hsu AJ. Valganciclovir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2023 June 08]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540577/10/Valganciclovir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Valganciclovir
ID - 540577
A1 - Pham,Paul,Pharm.D.
AU - Dzintars,Kathryn,Pharm.D., BCPS
AU - Hsu,Alice,Pharm.D.
Y1 - 2017/04/11/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540577/10/Valganciclovir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
